Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Italy Cell Banking Outsourcing Market

ID: MRFR/LS/49576-HCR
200 Pages
Satyendra Maurya
Last Updated: April 06, 2026

Italy Cell Banking Outsourcing Market Research Report: Size, Share, Trend Analysis By Bank Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type (Stem Cell Banking, Cord Stem Cell Banking, Embryonic Stem Cell Banking, Adult Stem Cell Banking, Dental Stem Cell Banking, IPS Stem Cell Banking, Non-Stem Cell Banking) and By Applications (Cell Bank Storage, Master Cell Bank Storage, Working Cell Bank Storage, Cell Storage Stability Testing, Cell Bank Preparation, Master Cell Bank Preparation, Working Cell Bank Preparation, Bank Characterization & Testing, Viral Cell Bank Safety Testing, Microbial Cell Bank Safety Testing, Gene Expression Testing, Karyology Testing, Gene Sequencing Testing) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Italy Cell Banking Outsourcing Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Construction, BY Bank Type (USD Million)
  49.     4.1.1 Master Cell Banking
  50.     4.1.2 Working Cell Banking
  51.     4.1.3 Viral Cell Banking
  52.   4.2 Construction, BY Cell Type (USD Million)
  53.     4.2.1 Stem Cell Banking
  54.     4.2.2 Cord Stem Cell Banking
  55.     4.2.3 Embryonic Stem Cell Banking
  56.     4.2.4 Adult Stem Cell Banking
  57.     4.2.5 Dental Stem Cell Banking
  58.     4.2.6 IPS Stem Cell Banking
  59.     4.2.7 Non-Stem Cell Banking
  60.   4.3 Construction, BY Application (USD Million)
  61.     4.3.1 Cell Bank Storage
  62.     4.3.2 Cell Bank Preparation
  63.     4.3.3 Bank Characterization & Testing
  64.     4.3.4 Viral Cell Bank Safety Testing
  65.     4.3.5 Microbial Cell Bank Safety Testing
  66.     4.3.6 Gene Expression Testing
  67.     4.3.7 Karyology Testing
  68.     4.3.8 Gene Sequencing Testing
  69. 5 SECTION V: COMPETITIVE ANALYSIS
  70.   5.1 Competitive Landscape
  71.     5.1.1 Overview
  72.     5.1.2 Competitive Analysis
  73.     5.1.3 Market share Analysis
  74.     5.1.4 Major Growth Strategy in the Construction
  75.     5.1.5 Competitive Benchmarking
  76.     5.1.6 Leading Players in Terms of Number of Developments in the Construction
  77.     5.1.7 Key developments and growth strategies
  78.       5.1.7.1 New Product Launch/Service Deployment
  79.       5.1.7.2 Merger & Acquisitions
  80.       5.1.7.3 Joint Ventures
  81.     5.1.8 Major Players Financial Matrix
  82.       5.1.8.1 Sales and Operating Income
  83.       5.1.8.2 Major Players R&D Expenditure. 2023
  84.   5.2 Company Profiles
  85.     5.2.1 Thermo Fisher Scientific (US)
  86.       5.2.1.1 Financial Overview
  87.       5.2.1.2 Products Offered
  88.       5.2.1.3 Key Developments
  89.       5.2.1.4 SWOT Analysis
  90.       5.2.1.5 Key Strategies
  91.     5.2.2 Merck KGaA (DE)
  92.       5.2.2.1 Financial Overview
  93.       5.2.2.2 Products Offered
  94.       5.2.2.3 Key Developments
  95.       5.2.2.4 SWOT Analysis
  96.       5.2.2.5 Key Strategies
  97.     5.2.3 Lonza Group (CH)
  98.       5.2.3.1 Financial Overview
  99.       5.2.3.2 Products Offered
  100.       5.2.3.3 Key Developments
  101.       5.2.3.4 SWOT Analysis
  102.       5.2.3.5 Key Strategies
  103.     5.2.4 Fujifilm Holdings Corporation (JP)
  104.       5.2.4.1 Financial Overview
  105.       5.2.4.2 Products Offered
  106.       5.2.4.3 Key Developments
  107.       5.2.4.4 SWOT Analysis
  108.       5.2.4.5 Key Strategies
  109.     5.2.5 Celerion (US)
  110.       5.2.5.1 Financial Overview
  111.       5.2.5.2 Products Offered
  112.       5.2.5.3 Key Developments
  113.       5.2.5.4 SWOT Analysis
  114.       5.2.5.5 Key Strategies
  115.     5.2.6 Cryoport, Inc. (US)
  116.       5.2.6.1 Financial Overview
  117.       5.2.6.2 Products Offered
  118.       5.2.6.3 Key Developments
  119.       5.2.6.4 SWOT Analysis
  120.       5.2.6.5 Key Strategies
  121.     5.2.7 BioLife Sciences (US)
  122.       5.2.7.1 Financial Overview
  123.       5.2.7.2 Products Offered
  124.       5.2.7.3 Key Developments
  125.       5.2.7.4 SWOT Analysis
  126.       5.2.7.5 Key Strategies
  127.     5.2.8 Cell and Gene Therapy Catapult (GB)
  128.       5.2.8.1 Financial Overview
  129.       5.2.8.2 Products Offered
  130.       5.2.8.3 Key Developments
  131.       5.2.8.4 SWOT Analysis
  132.       5.2.8.5 Key Strategies
  133.   5.3 Appendix
  134.     5.3.1 References
  135.     5.3.2 Related Reports
  136. 6 LIST OF FIGURES
  137.   6.1 MARKET SYNOPSIS
  138.   6.2 ITALY MARKET ANALYSIS BY BANK TYPE
  139.   6.3 ITALY MARKET ANALYSIS BY CELL TYPE
  140.   6.4 ITALY MARKET ANALYSIS BY APPLICATION
  141.   6.5 KEY BUYING CRITERIA OF CONSTRUCTION
  142.   6.6 RESEARCH PROCESS OF MRFR
  143.   6.7 DRO ANALYSIS OF CONSTRUCTION
  144.   6.8 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
  145.   6.9 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
  146.   6.10 SUPPLY / VALUE CHAIN: CONSTRUCTION
  147.   6.11 CONSTRUCTION, BY BANK TYPE, 2024 (% SHARE)
  148.   6.12 CONSTRUCTION, BY BANK TYPE, 2024 TO 2035 (USD Million)
  149.   6.13 CONSTRUCTION, BY CELL TYPE, 2024 (% SHARE)
  150.   6.14 CONSTRUCTION, BY CELL TYPE, 2024 TO 2035 (USD Million)
  151.   6.15 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
  152.   6.16 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
  153.   6.17 BENCHMARKING OF MAJOR COMPETITORS
  154. 7 LIST OF TABLES
  155.   7.1 LIST OF ASSUMPTIONS
  156.     7.1.1
  157.   7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  158.     7.2.1 BY BANK TYPE, 2025-2035 (USD Million)
  159.     7.2.2 BY CELL TYPE, 2025-2035 (USD Million)
  160.     7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  161.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  162.     7.3.1
  163.   7.4 ACQUISITION/PARTNERSHIP
  164.     7.4.1

Italy Construction Market Segmentation

Construction By Bank Type (USD Million, 2025-2035)

  • Master Cell Banking
  • Working Cell Banking
  • Viral Cell Banking

Construction By Cell Type (USD Million, 2025-2035)

  • Stem Cell Banking
  • Cord Stem Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
  • Non-Stem Cell Banking

Construction By Application (USD Million, 2025-2035)

  • Cell Bank Storage
  • Cell Bank Preparation
  • Bank Characterization & Testing
  • Viral Cell Bank Safety Testing
  • Microbial Cell Bank Safety Testing
  • Gene Expression Testing
  • Karyology Testing
  • Gene Sequencing Testing

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓